In a 70‑kg adult with severe community‑acquired pneumonia, when should steroids be administered and what is the appropriate dosing regimen?

Steroid Use in Severe Community-Acquired Pneumonia

For a 70-kg adult with severe community-acquired pneumonia, administer hydrocortisone ≤400 mg IV daily (or equivalent) for 5-7 days, initiated within 24 hours of developing severe disease. This recommendation is based on the most recent high-quality evidence showing mortality reduction and decreased need for mechanical ventilation in severe CAP 1.

Dosing Regimen

For your 70-kg patient with severe CAP, use one of these evidence-based regimens:

• Hydrocortisone: 50 mg IV every 6 hours (200 mg/day total) for 5-7 days 1, 2
• Methylprednisolone: 0.5-1 mg/kg/day IV (approximately 40-80 mg/day for 70 kg patient) for 5 days
• Dexamethasone: 6 mg IV/PO daily for 5-7 days (equivalent to ~240 mg hydrocortisone)

Do not exceed 400 mg hydrocortisone-equivalent daily - higher doses show no additional benefit and increase adverse effects 1.

Timing is Critical

Initiate steroids within 24 hours of developing severe CAP for maximum benefit 3. The CAPE COD trial demonstrated that early hydrocortisone administration (within 24 hours) improved 28-day mortality and reduced intubation risk, while the ESCAPe trial (which allowed initiation up to 72-96 hours) showed no benefit 3. This timing difference likely explains the divergent results between these major trials.

When to Use Steroids: Severity Criteria

Administer steroids when the patient meets criteria for severe CAP, defined by:

• Requiring ICU admission, OR
• Septic shock (hypotension requiring vasopressors despite adequate fluid resuscitation), OR
• Respiratory failure requiring mechanical ventilation or high-flow oxygen, OR
• CURB-65 score ≥3 or PSI class IV-V

The evidence is strongest for patients with severe disease - twelve trials showed mortality reduction most pronounced in severe rather than mild pneumonia (RR 0.67; 95% CI 0.45-1.01) 1. Do not use steroids routinely in non-severe CAP - there is no mortality benefit and only marginal reductions in hospital stay 4.

Critical Exception: Influenza

Do NOT use corticosteroids if influenza is confirmed or suspected 1, 5. Meta-analyses show increased mortality (OR 3.06; 95% CI 1.58-5.92) and higher secondary infection rates in influenza pneumonia treated with steroids 1. This represents systematic harm, not just lack of benefit. Test for influenza in all severe CAP patients during flu season before initiating steroids.

The exception is COVID-19 pneumonia requiring supplemental oxygen, where dexamethasone 6 mg daily reduces mortality 2.

Expected Benefits

When used appropriately in severe CAP, steroids provide:

• Reduced mortality in severe cases (RR 0.73; 95% CI 0.57-0.93) 4
• Decreased mechanical ventilation need (RR 0.45; 95% CI 0.26-0.79) 1
• Prevention of ARDS (RR 0.24; 95% CI 0.10-0.56) 1
• Shortened hospital stay by approximately 2-3 days 1, 4
• Reduced ICU length of stay by 1.7 days 4

Monitoring and Management of Adverse Effects

Hyperglycemia is the most common complication (RR 1.49; 95% CI 1.01-2.19) 1:

• Check blood glucose every 6 hours during steroid therapy
• Target glucose <180 mg/dL using insulin sliding scale
• Expect 20-38% of patients will require insulin 6

Other adverse effects to monitor:

• Gastrointestinal bleeding (no significant increase in trials, but monitor) 4
• Secondary infections (no significant increase demonstrated) 4
• Hypernatremia and neuropsychiatric effects 2

Duration and Tapering

Treat for 5-7 days maximum 1. Most trials used 4-8 days without tapering. For hydrocortisone at physiologic doses (≤200 mg/day for ≤7 days), tapering is generally unnecessary. For higher doses or longer durations, consider a brief 2-3 day taper.

Common Pitfalls to Avoid

1. Delayed initiation: Starting steroids >24 hours after severe CAP develops reduces efficacy 3
2. Using in non-severe CAP: No benefit demonstrated, only potential harm 4
3. Treating influenza pneumonia: Associated with increased mortality 1, 5
4. Excessive dosing: Doses >400 mg hydrocortisone-equivalent daily increase adverse effects without additional benefit 1
5. Prolonged courses: Treatment beyond 7-10 days increases complications without improving outcomes

Integration with Antibiotic Therapy

Steroids are adjunctive therapy only - always combine with appropriate empiric antibiotics. For severe CAP requiring ICU admission, use a β-lactam (cefotaxime, ceftriaxone, or ampicillin-sulbactam) plus either azithromycin or a fluoroquinolone 7.